85 results
8-K
EX-99.1
RNLX
Renalytix Plc
27 Aug 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00am
diagnostic experience, has designed its KidneyIntelX laboratory developed test to enable risk assessment for rapid progressive decline in kidney
8-K
EX-99.1
RNLX
Renalytix Plc
15 Jul 24
Issue of Shares and Rule 2.9 Announcement
7:30am
-stage CKD (stages 1-3b) risk assessment for progressive decline in kidney function in T2D patients. By understanding how disease will progress, patients
424B3
RNLX
Renalytix Plc
28 Jun 24
Prospectus supplement
4:26pm
-enabled algorithm to aid in assessment of the risk of progressive decline in kidney function. The test is designed to predict early in the progression
8-K
EX-99.1
RNLX
Renalytix Plc
17 Jun 24
Regulation FD Disclosure
4:30pm
to enable early-stage CKD (stages 1-3b) risk assessment for progressive decline in kidney function in T2D patients. By understanding how disease
8-K
EX-99.1
au8zscuz v6n2d2
28 May 24
Departure of Directors or Certain Officers
7:15am
424B5
q3m23rj
15 May 24
Prospectus supplement for primary offering
10:09am
8-K
EX-99.1
pkr d5wqf1zobm4
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
gp4539a9n nog5bhguiz
7 May 24
Prospectus supplement
6:29pm
8-K
EX-99.1
1zdja834mz9u 6nvf
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
EX-99.1
a2d3au87
10 Apr 24
Unregistered Sales of Equity Securities
4:01pm
424B5
oo9pbh lo7
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
41nsccu732cu2qhvtxk
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
EX-10.1
doxdk3 88zmnlgv
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.1
6ibtr3tbwlrfv2jjquzu
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
EX-10.1
onrhzz9f3ccvj3s
13 Mar 24
Entry into a Material Definitive Agreement
7:00am